Stock KTTA PASITHEA THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Pasithea Therapeutics Corp.

Equities

KTTA

US70261F2020

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-04-25 pm EDT 		5-day change 1st Jan Change
7.24 USD +4.17% Intraday chart for Pasithea Therapeutics Corp. +1.83% -2.16%
Apr. 24 Pasithea Therapeutics Corp. Announces the First Cohort Has Completed the Initial Dosing in Its Phase 1 Trial Evaluating Pas-004 in Ras, Nf1 and Raf Mutated Cancers CI
Mar. 29 Pasithea Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
EF Hutton Adjusts Price Target on Pasithea Therapeutics to $2 From $2.30, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KTTA Stock
  4. News Pasithea Therapeutics Corp.
  5. Analyst Reco.